Featuring perspectives from Dr Rahul Aggarwal, Dr Emmanuel S Antonarakis, Dr Elisabeth I Heath and Dr A Oliver Sartor, moderated by Dr Alan H Bryce, including the following topics:

• Introduction (0:00)
• Optimizing the Management of Nonmetastatic Prostate Cancer — Dr Aggarwal (1:51)
• Evidence-Based Selection of Treatment for Metastatic Hormone-Sensitive Prostate Cancer — Dr Antonarakis (25:39)
• New Considerations with PARP Inhibitors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Dr Bryce (47:31)
• Role of Novel Radiopharmaceuticals in Therapy for mCRPC — Dr Sartor (1:10:09)
• Promising Investigational Approaches for Patients with Prostate Cancer — Dr Heath (1:32:05)

CME information and select publications